Vilka är öppettiderna?

Måndag 09:00 - 17:00 Tisdag 09:00 - 17:00 Onsdag 09:00 - 17:00 Torsdag 09:00 - 17:00 Fredag 09:00 - 17:00

AMRA Medical

Hem
Sverige
Linköping
AMRA Medical

Our Vision is a new, fundamental way of thinking about health.

We leverage our proprietary MRI body composition analytics and deep expertise in disease research to deliver precise biomarkers – extracting insights from within your research or patient data to enhance your drug trial or clinical decision-making. AMRA is the first in the world to transform MR images into precise body composition measurements using a cloud-based, computer-aided service and a rapid MRI scan. Our imaging-based biomarkers (visceral fat, abdominal subcutaneous fat, liver fat, intramuscular fat, muscle group volumes, single muscle volumes, etc) are designed to play a long-term role in clinical trial development, research studies, and preventive care in a clinical setting. We collaborate with world-leading pharma, biobanks, research institutions, and hospitals, aiding in the advancement of metabolic research and its therapeutic application. With accurate knowledge about our bodies, we assist global medical leaders in predicting and preventing illnesses related to obesity-related and other metabolic disease, including diabetes, obesity, cardiovascular disease, liver disease, sarcopenia, musculoskeletal disorders, and more. We provide knowledge to the medical community so that every individual can become — and stay — healthy.

25/02/2026

Come chat with the AMRA Team at MDA 2026!

AMRA is gearing up to attend the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, taking place March 8–11 in Orlando! As one of the premier global meetings dedicated to advancing research, clinical care, and therapeutic development across neuromuscular diseases, MDA 2026 brings together leading clinicians, scientists, industry partners, and patient advocates committed to improving outcomes for individuals living with muscular dystrophy and related disorders.

Our team will be on site in Orlando and welcomes the opportunity to connect. If you are attending MDA 2026, we invite you to reach out to schedule a conversation about how AMRA can help power your neuromuscular trials with gold-standard muscle composition analysis. You can contact our team directly using their info below, or email info@amramedical.com to arrange a meeting.

We look forward to engaging with the community to explore how AMRA’s advanced imaging biomarkers can strengthen clinical trials and deepen our understanding of the future of neuromuscular disease research.

See you there!

Markus Karlsson, PhD
Conrad Maurais, MBA

23/02/2026

New Opportunity - Software Engineer!
Grow into an expert generalist in medical software.

Join our expanding team to build reliable systems that truly matter, collaborate closely with users and experienced colleagues, and develop across the full software lifecycle while deepening your technical expertise.

Read more about this position here: https://amramedical.com/about-us/career/

20/02/2026

Connect with the AMRA Team at the KDA 2026 Meeting in Orlando, Florida!

This year, AMRA is looking forward to attending the 2026 edition of the Kennedy’s Disease Association’s International Patient and Scientific Conference. The meeting, which runs from February 27th to March 3rd in Orlando, aims to advance “awareness, collaboration, and research toward a cure for Kennedy’s Disease.”

The AMRA team will be on site in Orlando, and is eager to set up time to chat about how AMRA can help you power your neuromuscular trials with our MRI-based biomarker solutions. If you’ll be at the meeting, reach out to any of our attending team members below, or reach out to info@amramedical.com.

We can’t wait to contribute to the conversation at KDA 2026!

Markus Karlsson, PhD
Mary Foltz, PhD
Conrad Maurais, MBA

19/02/2026

Join our team!

Would you like to work in a role where service, technology, and quality come together – and where your work truly makes a difference? We are now looking for an engaged Customer Support Agent to join our team in Linköping.

You will be part of AMRA’s operations department, working alongside the production team and customer project managers.

👉 Read more about the position here: https://amramedical.com/about-us/career/

18/02/2026

We are hiring!
We are looking for someone with a strong interest in the field of anatomy to join our team as an Analysis Engineer, working with quality review within the analysis of MRI images. The tasks involve reviewing large volumes of medical images and, when necessary, using AMRA’s software to adjust the segmented anatomy so that it aligns with the definition of a biomarker.

👉 Read more about the position here: https://amramedical.com/about-us/career/

29/01/2026

New Year, New Solutions: AMRA Medical Announces Brand Repositioning for 2026 and Beyond!

We are excited to share our brand repositioning supported by the launch of a refreshed website and the introduction of a new tagline, “Insights Within.” This strategic update reflects AMRA’s commitment to placing clients and collaborators at the center of our vision: to be the most trusted, insights-driven imaging partner in the pursuit of preventing and curing disease.

The new website provides a structured and transparent presentation of AMRA’s biomarkers and research services, enabling our partners to have a clear understanding of our offerings, as well as the scientific value and applications of these solutions.

The website also features AMRA’s brand new Knowledge Hub, which includes all-new Insights Articles written by our distinguished scientists, that share more about how our measures and technology are advancing fat distribution and muscle composition research.

You can read about the brand repositioning and explore our updated website here: https://amramedical.com/new-year-new-solutions-amra-medical-continues-commitment-to-innovation-data-driven-excellence/

If you’re looking to get in touch to learn more about how we can help you advance your clinical research pipeline or provide your clinical practice with detailed fat distribution and muscle composition analytics, reach out to us at info@amramedical.com to find a time to discuss with our team.

26/01/2026

Students to Scientists: AMRA Inspires the Next Generation at LiU!

Earlier today, we had the pleasure of seeing one of our own return to familiar ground! Hanna Heering, a Clinical Scientist at AMRA Medical and a recent graduate of Linköpings universitet (LiU), spoke to current students about her journey from studying chemical biology and protein science at LiU, to helping drive innovation in MRI-based fat and muscle analytics at AMRA.

During the luncheon, Hanna shared how a chance discovery of AMRA during her thesis search led her to a career focused on tackling some of today’s biggest health challenges, including obesity and type 2 diabetes. She also introduced students to the science behind AMRA’s technology: using advanced MRI analytics to precisely quantify fat and muscle composition, a method born right here at LiU.

AMRA’s roots in Linköping run deep, founded by researchers from LiU who were inspired to better understand human health. That early curiosity sparked a mission that now supports global clinical trials and healthcare decisions: all starting with local research and talent.

We’re proud to be part of the Linköping community and committed to fostering the next generation of scientific leaders. Whether it’s through internships, thesis collaborations, or events like this, AMRA continues to invest in education and the incredible minds coming out of LiU and Sweden.

A big thank you to Hanna for representing us so brilliantly, and to all the students who joined the session. We’re excited to see where your curiosity leads you next!

08/01/2026

AMRA Medical Brings AMRA® BCP Scan to the Netherlands Through Partnership with Prescan

We are pleased to announce the official launch of our cutting-edge AMRA® BCP Scan service, powered by AMRA® Profiler (CE, NB 2862), in the Netherlands. The launch, which marks BCP Scan’s third new market entry of 2025 (Sweden & Germany), expands the availability of our service within the EU into the Netherlands through an exclusive partnership with Prescan, an independent health & wellness clinic in Baarn which specializes in preventive health screenings and care.

The AMRA® BCP Scan service provides clinicians with fat distribution measurements, including visceral fat, subcutaneous fat and liver fat, in addition to muscle composition biomarkers that comprise a detailed body composition profile (BCP) to assist in the assessment of health risks.

At launch, Prescan will make AMRA® BCP Scan available to customers as a standalone product, and will be the only center offering BCP Scan in the Netherlands. Read more here: https://www.prescan.nl/en/mri-scan/mri-body-composition

Currently, AMRA® BCP Scan service is additionally available through AMRA’s service provision in the US, Canada, Sweden, Germany, the Netherlands, and the UK - with plans to roll out in more countries in 2026 and beyond.

Read more about the launch here: https://amramedical.com/amra-medical-introduces-amra-bcp-scan-in-the-netherlands-through-a-strategic-partnership-with-prescan-a-national-preventative-health-leader/

17/12/2025

As the year comes to an end, we wish you a joyful holiday season and every success in the year ahead. We’re looking forward to an exciting 2026!

Warm holiday wishes from all of us at AMRA!

04/12/2025

AMRA Medical To Present New Research on Fat Distribution & Muscle Composition in Heart Failure at the 22nd Global CVCT Forum

We are excited to share that we will be attending and presenting at the 22nd iteration of the CVCT - Cardiovascular Clinical Trialists Forum, happening December 8-10 at The Mayflower Hotel in Washington, D.C.!

AMRA is looking forward to contributing to the conversation at CVCT 2025, most notably by sharing results from a recent study done in collaboration with Javed Butler, MD, MPH, MBA from the Baylor Scott & White Research Institute, and Linköping University. Given the lack of normative data regarding body composition in individuals with heart failure (HF), the study aimed to provide reference data for fat distribution and muscle composition in 185 participants with HF based on the UK Biobank imaging study.

The results showed that HF was characterized by subtle but consistent alterations in fat distribution and marked muscle derangements, rather than overt obesity or sarcopenia, and suggest that traditional indices for obesity and sarcopenia underestimate the burden of metabolic and musculoskeletal derangements in HF. This study comes at a pivotal time in the heart failure trials space as ongoing studies assess the use of weight-loss therapies for management within HF populations, with associated concerns surrounding loss of muscle mass and onset of sarcopenia.

Are you attending CVCT 2025? You can learn more about the study and its findings by visiting us at our poster, presented by Jennifer Linge, PhD, or by connecting with us at info@amramedical.com to find a time to discuss with our team on site in D.C.. We would love to see you there and talk about how AMRA’s various offerings can help move your science and clinical care practice forward, in cardiovascular disease and beyond.

01/12/2025

The 2nd Annual Innovation in Obesity Therapeutics Summit is here!

AMRA’s CEO, Dr. Olof Dahlqvist Leinhard, discusses how transformative MRI-based body composition methods and AMRA’s unique biomarkers are redefining obesity drug trials.

➜ "MRI-based Body Composition Reimagined: Building a New Foundation for Treatment Differentiation Beyond Weight Loss"
➜ Olof Dahlqvist Leinhard, PhD
➜ December 3rd, 2:10pm

This talk covers:

‣ FDA-cleared MRI-based body composition analysis provides a new standard for muscle and fat quantification enabling translation from population studies and clinical trials all the way into healthcare.

‣ Studies on Personalized Fat and Muscle Z-score biomarkers show improved prediction of outcomes and that weight- and BMI-invariant treatment effects can be detected.

‣ Understanding loss of muscle mass and shifts in fat distribution in the context of weight reduction and exploring the varying effects of liraglutide and tirzepatide in recent clinical trials.

Read about the talk and the conference here: https://tinyurl.com/3hk5ft9k

If you would like to connect, reach out to Leanna Kellerman via info@amramedical.com.

Interested in this topic? Read our Insights Article to learn more:
https://tinyurl.com/39zewvzs

20/11/2025

AMRA is at LINK-dagarna this week — Linköping University’s student career fair — meeting the next generation of bright minds in IT and Data 🚀

Adress

Badhusgatan 5
Linköping
58222

Öppettider

Måndag	09:00 - 17:00
Tisdag	09:00 - 17:00
Onsdag	09:00 - 17:00
Torsdag	09:00 - 17:00
Fredag	09:00 - 17:00

Telefon

+4613162600

Webbplats

http://www.amramedical.com/

Aviseringar

Var den första att veta och låt oss skicka ett mail när AMRA Medical postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Praktiken

Skicka ett meddelande till AMRA Medical:

Genvägar

Vill du placera din praktik längst upp i Klinik-listan i Linköping?

Dela

Typ

Health/Medical/ Pharmaceuticals

Our Story

AMRA is a ground-breaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, rapid, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.

Imbalances between muscle and fat are linked to a multitude of diseases and to some of the greatest challenges for patients and healthcare systems globally. A detailed understanding of body composition is, therefore, vital for identifying and tracking health and metabolic status, diseases or injuries, and overall fitness.

AMRA’s current research and application areas include Obesity, CVD, Diabetes, NAFLD/NASH, Oncology, Sarcopenia, Cachexia, CNS/Neuromuscular and Musculoskeletal Disorders, and Rare Diseases - in both adult and pediatric populations. Our Vision is a new, fundamental way of thinking about health. We provide knowledge to the medical community so that every individual can become — and stay — healthy.